Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?

Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics

Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?

What's in the Cards for Amgen (AMGN) This Earnings Season?

Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?

Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results

Buy Rating Affirmed for Alnylam Pharma on Strong Zilebesiran Trial Results and Lucrative Roche Partnership

Alnylam Pharma Earns Buy Rating on Robust Clinical Trials and Strategic Partnerships

Why Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick

Why Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick

Jefferies Keeps Their Buy Rating on Alnylam Pharma (ALNY)

Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), ALX Oncology Holdings (ALXO)

Alnylam Pharma (ALNY) Gets a Hold from J.P. Morgan

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension

Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alnylam Pharma (ALNY)